The TPT payment, effective Jan. 1, 2024, will last for 24–36 months, allowing incremental reimbursement for outpatient procedures using the device.
The aScope 5 Broncho HD series is Ambu’s latest generation of single-use bronchoscope. Cleared by the FDA in 2022, it has advanced imaging and design features, including a new high-resolution camera chip. It’s part of a single-use portfolio that Ambu has grown over the past 14 years to include 10 different bronchoscopy models designed to meet patient needs in interventional pulmonology, critical care medicine, and anesthesia and airway management. T
Ambu said the TPT was granted to the aScope 5 Broncho HD series because it fit CMS criteria, which included demonstrating a substantial clinical improvement over existing sing…